International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8076783
Original Article
Study of Red Cell Distribution Width in Heart Failure Patients and its Correlation with Severity of Heart Failure
 ,
 ,
Published
June 24, 2023
Abstract
Background: Heart failure is a prevalent and chronic condition with a rising incidence globally, including in India. Red cell distribution width (RDW), a measure of erythrocyte size variation, has been proposed as an indicator of inflammation and oxidative stress in cardiovascular diseases, including heart failure. However, limited data exist on the relationship between RDW and heart failure severity in Indian patients. This study aimed to investigate the correlation between RDW and the severity of heart failure in Indian patients. Result: The study included patients across various age groups, with the majority falling in the 51-60 years range, and most of the patients were male. Hypertension was the most common risk factor for heart failure, followed by dyslipidemia and obesity. Ischemic heart disease emerged as the primary cause of heart failure in the studied population. Distribution of patients based on NYHA classes revealed a higher percentage in the more severe classes (III and IV). The mean RDW was significantly higher in patients with advanced heart failure compared to those with milder forms. Conclusion: The study findings indicate a correlation between elevated RDW and increased severity of heart failure in Indian patients. RDW shows potential as a biomarker for risk stratification and monitoring disease progression in this population. Further research is needed to explore the clinical utility of RDW in the early detection and management of heart failure, along with its implications for developing new therapeutic approaches specific to the Indian context.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1355 Views
254 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved